{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "marketState": "PRE", "regularMarketPrice": 0.0001, "exchangeTimezoneShortName": "EDT", "exchangeTimezoneName": "America/New_York", "currency": "USD", "market": "us_market", "esgPopulated": false, "messageBoardId": "finmb_5874762", "gmtOffSetMilliseconds": -14400000, "shortName": "NUGENEREX IMMUNO-ONCOLOGY INC", "longName": "NuGenerex Immuno-Oncology, Inc.", "regularMarketChangePercent": 0.0, "exchange": "PNK", "regularMarketChange": 0.0, "regularMarketTime": 1683316277, "regularMarketDayHigh": 0.0001, "regularMarketDayRange": "1.0E-4 - 1.0E-4", "regularMarketDayLow": 0.0001, "regularMarketVolume": 6, "regularMarketPreviousClose": 0.0001, "fullExchangeName": "Other OTC", "financialCurrency": "USD", "regularMarketOpen": 0.0001, "averageDailyVolume3Month": 95, "averageDailyVolume10Day": 60, "fiftyTwoWeekLowChange": 9e-05, "tradeable": false, "cryptoTradeable": false, "fiftyTwoWeekLowChangePercent": 9.0, "fiftyTwoWeekRange": "1.0E-5 - 0.3", "fiftyTwoWeekHighChange": -0.29990003, "fiftyTwoWeekHighChangePercent": -0.9996667, "fiftyTwoWeekLow": 1e-05, "fiftyTwoWeekHigh": 0.3, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.06, "sharesOutstanding": 100300000, "bookValue": -0.088, "fiftyDayAverage": 0.009161, "fiftyDayAverageChange": -0.009061, "fiftyDayAverageChangePercent": -0.9890842, "twoHundredDayAverage": 0.0023396, "twoHundredDayAverageChange": -0.0022395998, "twoHundredDayAverageChangePercent": -0.9572576, "marketCap": 10030, "priceToBook": -0.0011363636, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "firstTradeDateMilliseconds": 1615815000000, "priceHint": 4, "displayName": "NuGenerex Immuno-Oncology", "symbol": "NUGX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "10102 USA Today Way", "city": "Miramar", "state": "FL", "zip": "33025", "country": "United States", "phone": "416 364 2551", "website": "https://www.generex.com/nugenerex-family-of-companies", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "NuGenerex Immuno-Oncology, Inc., an oncology company, focuses on the modulation of the immune system to treat cancer. The company is developing immunotherapeutic products and vaccines. It is developing AE37, a peptide immunotherapeutic vaccine, which is in Phase II clinical trials for the treatment of metastatic triple negative breast cancer. The company was formerly known as Antigen Express, Inc. The company was founded in 1993 and is based in Miramar, Florida. NuGenerex Immuno-Oncology, Inc.is a subsidiary of Generex Biotechnology Corporation.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph  Moscato", "age": 58, "title": "CEO, Pres & Chairman", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mark  Corrao", "age": 64, "title": "Chief Financial Officer", "yearBorn": 1958, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Eric  von Hofe Ph.D.", "age": 67, "title": "Chief Scientific Officer", "yearBorn": 1955, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Anthony S. Crisci CPA, Esq.", "age": 51, "title": "Corp. Counsel, Chief Legal Officer, Sec. & Director", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jason B. Terrell M.D.", "age": 49, "title": "Chief Medical Officer", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Richard D. Purcell", "age": 61, "title": "Exec. VP of R&D and Director", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}